I agree that this site is using cookies. You can find further informations here.
X
Radia, Deepti H.
163  results:
Search for persons X
?
1

Allogeneic haematopoietic cell transplantation for advanced..:

McLornan, Donal P. ; Czerw, Tomasz ; Damaj, Gandhi...
Leukemia.  38 (2024)  4 - p. 699-711 , 2024
Link: https://doi.org/10.1038/..
 
?
2

POSTER: MPN-295 Avapritinib in Patients With Advanced Syste..:

Gotlib, Jason ; Reiter, Andreas ; Radia, Deepti H....
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S193 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Systemic mastocytosis 

Fast facts for healthcare professionals
Radia, Deepti H ; Akin, Cem , 2023
Link: https://search.ebscohost..
 
?
4

Recent Advances in the Therapeutic Management of Advanced S..:

Veitch, Scott ; Radia, Deepti H.
Diagnostics.  14 (2023)  1 - p. 80 , 2023
Link: https://doi.org/10.3390/..
 
?
5

POSTER: MPN-524 Reductions in Indolent Systemic Mastocytosi..:

Gotlib, Jason ; Castells, Mariana ; Elberink, Hanneke Oude...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S194 , 2023
Link: https://doi.org/10.1016/..
 
?
6

The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/..:

Valent, Peter ; Hoermann, Gregor ; Bonadonna, Patrizia...
The Journal of Allergy and Clinical Immunology: In Practice.  11 (2023)  10 - p. 3010-3020 , 2023
Link: https://doi.org/10.1016/..
 
?
7

MPN-524 Reductions in Indolent Systemic Mastocytosis Biomar..:

Gotlib, Jason ; Castells, Mariana ; Elberink, Hanneke Oude...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S398-S399 , 2023
Link: https://doi.org/10.1016/..
 
?
8

CNL and aCML should be considered as a single entity based ..:

Carreño-Tarragona, Gonzalo ; Álvarez-Larrán, Alberto ; Harrison, Claire...
Blood Advances.  7 (2023)  9 - p. 1672-1681 , 2023
Link: https://doi.org/10.1182/..
 
?
9

MPN-295 Avapritinib in Patients With Advanced Systemic Mast..:

Gotlib, Jason ; Reiter, Andreas ; Radia, Deepti H....
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S388-S389 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Efficacy and safety of avapritinib in previously treated pa..:

Reiter, Andreas ; Schwaab, Juliana ; DeAngelo, Daniel J....
Blood Advances.  6 (2022)  21 - p. 5750-5762 , 2022
Link: https://doi.org/10.1182/..
 
?
11

Efficacy of avapritinib versus best available therapy in th..:

Reiter, Andreas ; Gotlib, Jason ; Álvarez-Twose, Iván...
Leukemia.  36 (2022)  8 - p. 2108-2120 , 2022
Link: https://doi.org/10.1038/..
 
?
12

Update on diagnostic approaches and therapeutic strategies ..:

Radia, Deepti H. ; Moonim, Mufaddal T.
Best Practice & Research Clinical Haematology.  35 (2022)  2 - p. 101380 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Personalized Management Strategies in Mast Cell Disorders: ..:

Valent, Peter ; Hartmann, Karin ; Schwaab, Juliana...
The Journal of Allergy and Clinical Immunology: In Practice.  10 (2022)  8 - p. 1999-2012.e6 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Evidence of robust memory T‐cell responses in patients with..:

Harrington, Patrick ; Harrison, Claire N. ; Dillon, Richard...
British Journal of Haematology.  193 (2021)  4 - p. 692-696 , 2021
Link: https://doi.org/10.1111/..
 
?
15

Safety and efficacy of avapritinib in advanced systemic mas..:

DeAngelo, Daniel J. ; Radia, Deepti H. ; George, Tracy I....
Nature Medicine.  27 (2021)  12 - p. 2183-2191 , 2021
Link: https://doi.org/10.1038/..
 
1-15